Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?
Authors
Keywords
Aerosols, Antibiotics, Breathing, Inhalation, Sputum, Tidal volume, Cystic fibrosis, Pulmonary function
Journal
PLoS One
Volume 10, Issue 3, Pages e0118454
Publisher
Public Library of Science (PLoS)
Online
2015-03-04
DOI
10.1371/journal.pone.0118454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients
- (2014) Axel Dalhoff CLINICAL MICROBIOLOGY REVIEWS
- Inhaled antibiotics for the treatment of chronic bronchopulmonaryPseudomonas aeruginosainfection in cystic fibrosis: systematic review of randomised controlled trials
- (2013) Luis Máiz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Inhaled aztreonam lysine: an evidence-based review
- (2013) David Hutchinson et al. EXPERT OPINION ON PHARMACOTHERAPY
- Distribution of Early Structural Lung Changes due to Cystic Fibrosis Detected with Chest Computed Tomography
- (2013) Lauren S. Mott et al. JOURNAL OF PEDIATRICS
- Identifying the Origins of Cystic Fibrosis Lung Disease
- (2013) Stephanie D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Functional Imaging of Changes in Small Airways of Patients Treated with Extrafine Beclomethasone/Formoterol
- (2013) Wim Vos et al. RESPIRATION
- High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms
- (2012) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?
- (2012) Martine Loeve et al. EUROPEAN RESPIRATORY JOURNAL
- A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data
- (2012) Samir Vinchurkar et al. INHALATION TOXICOLOGY
- Using MRI to Measure Aerosol Deposition
- (2012) Richard B. Thompson et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Cystic Fibrosis: The Role of the Small Airways
- (2012) Felix Ratjen Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Aerosol Deposition in Health and Disease
- (2012) Chantal Darquenne Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogenPseudomonas aeruginosa
- (2012) C.G. Nair et al. LETTERS IN APPLIED MICROBIOLOGY
- Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid
- (2011) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
- (2011) E. M. Bakker et al. EUROPEAN RESPIRATORY JOURNAL
- The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study
- (2011) Lieve A. De Backer et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Bronchoalveolar Lavage–Directed Therapy on Pseudomonas aeruginosa Infection and Structural Lung Injury in Children With Cystic Fibrosis
- (2011) Claire E. Wainwright et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine
- (2010) J Stuart Elborn et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects
- (2010) Warren Lenney et al. Journal of Cystic Fibrosis
- Cystic fibrosis lung disease starts in the small airways: Can we treat it more effectively?
- (2010) Harm A.W.M. Tiddens et al. PEDIATRIC PULMONOLOGY
- An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis
- (2010) Christopher M. Oermann et al. PEDIATRIC PULMONOLOGY
- Validation of Computational Fluid Dynamics in CT-based Airway Models with SPECT/CT
- (2010) Jan W. De Backer et al. RADIOLOGY
- In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
- (2009) P. King et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
- (2009) George Z. Retsch-Bogart et al. CHEST
- The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease
- (2009) M Loeve et al. THORAX
- Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis
- (2008) Karen S. McCoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The science of aerosol delivery in cystic fibrosis
- (2008) David E. Geller PEDIATRIC PULMONOLOGY
- Reference Ranges for Spirometry Across All Ages
- (2007) Sanja Stanojevic et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation
- (2007) J.W. De Backer et al. JOURNAL OF BIOMECHANICS
- Flow analyses in the lower airways: Patient-specific model and boundary conditions
- (2007) J.W. De Backer et al. MEDICAL ENGINEERING & PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now